83 related articles for article (PubMed ID: 26247350)
21. Bayes factors for superiority, non-inferiority, and equivalence designs.
van Ravenzwaaij D; Monden R; Tendeiro JN; Ioannidis JPA
BMC Med Res Methodol; 2019 Mar; 19(1):71. PubMed ID: 30925900
[TBL] [Abstract][Full Text] [Related]
22. Bayesian Design of Non-Inferiority Clinical Trials via the Bayes Factor.
Li W; Chen MH; Wangy X; Dey DK
Stat Biosci; 2018 Aug; 10(2):439-459. PubMed ID: 30344778
[TBL] [Abstract][Full Text] [Related]
23. A simulation study of the strength of evidence in the recommendation of medications based on two trials with statistically significant results.
van Ravenzwaaij D; Ioannidis JP
PLoS One; 2017; 12(3):e0173184. PubMed ID: 28273140
[TBL] [Abstract][Full Text] [Related]
24. Bayesian approach to noninferiority trials for proportions.
Gamalo MA; Wu R; Tiwari RC
J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
[TBL] [Abstract][Full Text] [Related]
25. Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint.
Ghosh S; Tiwari RC; Ghosh S
Pharm Stat; 2018 Jul; 17(4):342-357. PubMed ID: 29473291
[TBL] [Abstract][Full Text] [Related]
26. The network meta-analytic-predictive approach to non-inferiority trials.
Schmidli H; Wandel S; Neuenschwander B
Stat Methods Med Res; 2013 Apr; 22(2):219-40. PubMed ID: 22218367
[TBL] [Abstract][Full Text] [Related]
27. Evidence synthesis from aggregate recurrent event data for clinical trial design and analysis.
Holzhauer B; Wang C; Schmidli H
Stat Med; 2018 Mar; 37(6):867-882. PubMed ID: 29152777
[TBL] [Abstract][Full Text] [Related]
28. Approaches for testing noninferiority in two-arm trials for risk ratio and odds ratio.
Chowdhury S; Tiwari RC; Ghosh S
J Biopharm Stat; 2019; 29(3):425-445. PubMed ID: 30744476
[TBL] [Abstract][Full Text] [Related]
29. Bayesian methods for the design and analysis of noninferiority trials.
Gamalo-Siebers M; Gao A; Lakshminarayanan M; Liu G; Natanegara F; Railkar R; Schmidli H; Song G
J Biopharm Stat; 2016; 26(5):823-41. PubMed ID: 26247350
[TBL] [Abstract][Full Text] [Related]
30. Bayesian randomized clinical trials: From fixed to adaptive design.
Yin G; Lam CK; Shi H
Contemp Clin Trials; 2017 Aug; 59():77-86. PubMed ID: 28455232
[TBL] [Abstract][Full Text] [Related]
31. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
Kaul S; Diamond GA
Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
[TBL] [Abstract][Full Text] [Related]
32. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
Liu GF
Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
[TBL] [Abstract][Full Text] [Related]
33. Placebo or active control trials of antipsychotic drugs?
Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
